Back to User profile » Dr Iveth Mendoza Salas
Papers published by Dr Iveth Mendoza Salas:
CYP3A5 Polymorphism in Circulating Tumor Cells Confers an Increased Disease-Free Survival in DLBCL Patients Treated with R-CHOP
Cerón Maldonado R, Martínez Tovar A, Ramos Peñafiel CO, De la Cruz Rosas A, García Laguna AI, Mendoza Salas I, Martínez Murillo C, Barranco Lampón GI, Montaño Figueroa EH, Jiménez-Morales S, Olarte Carrillo I
OncoTargets and Therapy 2025, 18:355-366
Published Date: 14 March 2025
Overexpression of BCL2, BCL6, VEGFR1 and TWIST1 in Circulating Tumor Cells Derived from Patients with DLBCL Decreases Event-Free Survival
Cerón R, Martínez A, Ramos C, De la Cruz A, García A, Mendoza I, Palmeros G, Montaño Figueroa EH, Navarrete J, Jiménez-Morales S, Martinez-Murillo C, Olarte I
OncoTargets and Therapy 2022, 15:1583-1595
Published Date: 30 December 2022
Impact of the ABCB1 Drug Resistance Gene on the Risk Factors of Patients with COVID-19 and Its Relationship with the Drugs Used
Olarte Carrillo I, Ramos Peñafiel CO, Mendoza Salas I, Cerón Maldonado R, García Laguna AI, De la Cruz Rosas A, Martinez Murrillo C, Martinez Tovar A
Infection and Drug Resistance 2022, 15:2661-2669
Published Date: 24 May 2022